About Company
The Sangui Biotech GmbH carries out research and development around the care of the human body with oxygen. Patents and know-how, unique technologies and formulations lead to products and their applications. We place the legalization and marketing of these products in the hands of competent specialists: out-licensing to partners or joint ventures, income from licensing income and dividends.
The first major milestone was the market launch of the
The Sangui Biotech GmbH carries out research and development around the care of the human body with oxygen. Patents and know-how, unique technologies and formulations lead to products and their applications. We place the legalization and marketing of these products in the hands of competent specialists: out-licensing to partners or joint ventures, income from licensing income and dividends.
The first major milestone was the market launch of the hemoglobin-based wound spray Granulox by the joint venture SastoMed GmbH. A major project and strategic focus is the development of artificial oxygen carriers (hemoglobin hyperpolymers) as an internal therapy for acute oxygen deficiency.
